Genmab (GMAB) Shares Double Following Successful Cancer Drug Trials
Genmab's shares have surged following significant successes in cancer drug trials, marking a pivotal shift in the company's strategy towards greater ownership of its treatments. This momentum could enhance its revenue potential and position in the biotech sector.